Reducing surgical site infections by bundling multiple risk reduction strategies and active surveillance

AORN Journal

Volumn 92, Issue 3, 2010, Pages 288-296

  Lipke, Virginia Leigh ^a   Hyott, Anthony S ^a  

^a MedBio Publications   (United States)

Author keywords

2 CHG cloths; Chlorhexidine gluconate; Health care associated infection; Methicillin resistant Staphylococcus aureus; Preoperative skin preparation; Surgical site infection

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; RISK REDUCTION; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION SURVEILLANCE; RISK REDUCTION BEHAVIOR; SURGICAL WOUND INFECTION;

EID: 77956241481     PISSN: 00012092     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aorn.2010.01.016     Document Type: Article

References (29)

1. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999, 20(4):250-280. Hospital Infection Control Practices Advisory Committee.
2. Neumayer L., Hosokawa P., Itani K., El-Tamer M., Henderson W.G., Khuri S.F. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 2007, 204(6):1178-1187.
3. Engemann J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36(5):592-598.
4. McGarry S.A., Engemann J.J., Schmader K., Sexton D.J., Kaye K.S. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 2004, 25(6):461-467.
5. Cantlon C.A., Stemper M.E., Schwan W.R., Hoffman M.A., Qutaishat S.S. Significant pathogens isolated from surgical site infections at a community hospital in the Midwest. Am J Infect Control 2006, 34(8):526-529.
6. Maree C.L., Daum R.S., Boyle-Vavra S., Matayoshi K., Miller L.G. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007, 13(2):236-242.
7. Kourbatova E.V., Halvosa J.S., King M.D., Ray S.M., White N., Blumberg H.M. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005, 33(7):385-391.
8. Patel M., Kumar R.A., Stamm A.M., Hoesley C.J., Moser S.A., Waites K.B. USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. J Clin Microbiol 2007, 45(10):3431-3433.
9. Beigi R., Hanrahan J. Staphylococcus aureus and MRSA colonization rates among gravidas admitted to labor and delivery: a pilot study. Infect Dis Obstet Gynecol 2007, 2007:70876.
10. Cheadle W.G. Risk factors for surgical site infection. Surg Infect (Larchmt) 2006, 7(Suppl 1):S7-S11.
11. Davis K.A., Stewart J.J., Crouch H.K., Florez C.E., Hospenthal D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004, 39(6):776-782.
12. Livingston B. Challenges and experience with implementing patient preoperative skin preparation in a Veterans Administration (VA) Health System to prevent surgical site infections Poster presented at: Association for Professionals in Infection Control and Epidemiology (APIC), San Jose, CA; June 24, 2007, Accessed May 13, 2010. http://www.sageproducts.com/documents/pdf/education/symposia/ssi/20973_Challenges_and_Experience_with_Implementing_Patient_Preoperative_Skin_Preparation_in_a_Veterans_Administration_VA_Health_System_to_Prevent_Surgical_Site_Infections.pdf.
13. Choban P.S., Heckler R., Burge J.C., Flancbaum L. Increased incidence of nosocomial infections in obese surgical patients. Am Surg 1995, 61(11):1001-1005.
14. Kabon B., Nagele A., Reddy D., et al. Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004, 100(2):274-280.
15. Getting Started Kit: Prevent Surgical Site Infections How-to Guide 2008, 5 Million Lives Campaign, Institute for Healthcare Improvement, Cambridge, MA.
16. Jackson M.M. Topical antiseptics in healthcare. Clin Lab Sci 2005, 18(3):160-169.
17. DeBaun B. Evaluation of the antimicrobial properties of an alcohol-free 2% chlorhexidine gluconate solution. AORN J 2008, 87(5):925-933.
18. Vernon M.O., Hayden M.K., Trick W.E., Hayes R.A., Blom D.W., Weinstein R.A. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006, 166(3):306-312. Chicago Antimicrobial Resistance Project (CARP).
19. Maki D.G., Paulson D.S. Prospective evaluation of 6 preoperative cutaneous antiseptic regimens for prevention of surgical site infection March 2006, Poster presented at: Society for Healthcare Epidemiology of America (SHEA) Conference; Chicago, IL.
20. Edmiston C.E., Seabrook G.R., Johnson C.P., Paulson D.S., Beausoleil C.M. Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control 2007, 35(2):89-96.
21. Leigh D.A., Stronge J.L., Marriner J., Sedgwick J. Total body bathing with "Hibiscrub" (chlorhexidine) in surgical patients: a controlled trial. J Hosp Infect 1983, 4(3):229-235.
22. Webster J., Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2007, (2). CD004985.
23. Rhee H., Harris B. Reducing Surgical site infection: 2% CHG cloth reduces SSI rates by > 70% difference resulting in a $154,869 cost avoidance May 23, 2007, Poster presented at: The Virginians Improving Patient Care and Safety (VIPC&S) 7th Annual Conference; Richmond, VA.
24. Bleasdale S.C., Trick W.E., Gonzalez I.M., Lyles R.D., Hayden M.K., Weinstein R.A. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007, 167(19):2073-2079.
25. Blanchard K., Jefferson J., Mermel L. Control of nosocomial Acinetobacter in a university-affiliated medical center June 2007, Poster presented at: Association for Professionals in Infection Control and Epidemiology (APIC) meeting; San Jose, CA.
26. Wernitz M.H., Swidsinski S., Weist K., et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect 2005, 11(6):457-465.
27. Nicholson M.R., Huesman L.A. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006, 34(1):44-48.
28. Carrier M., Marchand R., Auger P., et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg 2002, 123(1):40-44.
29. Living with MRSA: Learning How to Control the Spread of Methicillin-Resistant Staphylococcus Aureus (MRSA) March 20, 2006, Washington State Department of Health, Tacoma-Pierce County Health Department, Group Health Cooperative, MultiCare Health Systems, Accessed June 29, 2010. http://here.doh.wa.gov/materials/living-with-mrsa/12_MRSApage_E07L.pdf.